Adaptive Biotechnologies Corp (ADPT) financials · rev $277.0M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Adaptive Biotechnologies Corp (ADPT) rev $277.0M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $277.0M | $179.0M |
| Cost of Revenue | $71.4M | $72.1M |
| Gross Profit | $205.6M | $106.9M |
| Operating Income | -$57.1M | -$162.5M |
| Net Income | -$59.5M | -$159.5M |
| EPS (Diluted) | -$0.39 | -$1.08 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $512.7M | $539.4M |
| Current Assets | $300.2M | $283.8M |
| Cash & Equivalents | $70.5M | $47.9M |
| Inventory | $9.82M | $8.44M |
| PP&E | $34.1M | $48.6M |
| Total Liabilities | $287.7M | $336.9M |
| Current Liabilities | $89.9M | $98.1M |
| Short-term Debt | $4.64M | $865.0K |
| Long-term Debt | $126.6M | $132.4M |
| Total Debt | $131.2M† | $133.3M† |
| Shareholders' Equity | $218.8M | $202.7M |
| Retained Earnings | -$1.36B | -$1.30B |
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$46.0M | -$95.2M |
| CapEx | $2.96M | $3.66M |
| Investing Cash Flow | $38.0M | $77.8M |
| Financing Cash Flow | $30.4M | $241.0K |
| Net Change in Cash | $22.4M | -$17.2M |
| Free Cash Flow | -$48.9M | -$98.9M |
FAQ
What is ADPT P/E and revenue?
Adaptive Biotechnologies Corp (ADPT) rev $277.0M.
What is ADPT revenue?
Adaptive Biotechnologies Corp last cached revenue is $277.0M (FY2025).
Is ADPT profitable?
Adaptive Biotechnologies Corp last cached net income is -$59.5M (FY2025).
What are ADPT total assets?
Adaptive Biotechnologies Corp last cached total assets are $512.7M (FY2025).
What is ADPT free cash flow?
Adaptive Biotechnologies Corp last cached free cash flow is -$48.9M (FY2025).
Not investment advice. Cached statements, not a live tape.